Literature DB >> 31933140

Ivor Lewis vs Mckeown esophagectomy: analysis of operative outcomes from the ACS NSQIP database.

M J Sabra1, Y A Alwatari2, L G Wolfe1, A Xu1, B J Kaplan1, A D Cassano1, R D Shah1.   

Abstract

OBJECTIVES: Ivor Lewis and McKeown esophagectomy are common techniques to treat esophageal cancer. In this study, we aim to compare these two approaches.
METHOD: We used the American College of Surgeons National Surgical Quality Improvement Project database (2005-2017) to compare both techniques using bivariate analysis after propensity matching.
RESULTS: We identified 6136 patients with esophagectomy and divided them into 2 groups based on whether they received a McKeown (1676; 27.31%) or an Ivor Lewis (4460; 70.14%) esophagectomy. McKeown esophagectomy was associated with higher rates of superficial surgical site infections (8.02% vs 3.67%, p < 0.001), anastomotic leaks (9.12% vs 7.71%, p = 0.02), prolonged intubation (15.06% vs 10.10%, p < 0.001), re-intubation (15.30% vs 10.34%, p ≤ 0.001), and return to the OR (16.46% vs 11.32%, p < 0.001). The McKeown esophagectomy patients also had longer hospital length of stay (14.5 ± 11.99 vs 13.37 ± 11.8, p = 0.002), higher re-admission rate (21.56% vs 16.87%, p = 0.002), and higher discharges to nursing/rehabilitation institutions (14.06% vs 11.99%, p = 0.004).The mortality rate and positive resection margins were not significantly different. There was a trend toward more utilization of Ivor Lewis esophagectomy over years.
CONCLUSION: When compared to Ivor Lewis esophagectomy, McKeown esophagectomy is associated with more unplanned intubation, increased difficulty weaning from the ventilator, incisional surgical site infections, anastomotic leak, and higher length of stay.

Entities:  

Keywords:  Esophagectomy; Ivor-Lewis; McKeown; NSQIP; Outcomes

Year:  2020        PMID: 31933140     DOI: 10.1007/s11748-020-01290-w

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  23 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Open versus minimally invasive esophagectomy: trends of utilization and associated outcomes in England.

Authors:  Antonio Ivan Lazzarino; Kamal Nagpal; Alex Bottle; Omar Faiz; Krishna Moorthy; Paul Aylin
Journal:  Ann Surg       Date:  2010-08       Impact factor: 12.969

3.  Comparative outcomes of minimally invasive and robotic-assisted esophagectomy.

Authors:  Kenneth Meredith; Paige Blinn; Taylor Maramara; Caitlin Takahashi; Jamie Huston; Ravi Shridhar
Journal:  Surg Endosc       Date:  2019-06-10       Impact factor: 4.584

4.  Development and use of an administrative claims measure for profiling hospital-wide performance on 30-day unplanned readmission.

Authors:  Leora I Horwitz; Chohreh Partovian; Zhenqiu Lin; Jacqueline N Grady; Jeph Herrin; Mitchell Conover; Julia Montague; Chloe Dillaway; Kathleen Bartczak; Lisa G Suter; Joseph S Ross; Susannah M Bernheim; Harlan M Krumholz; Elizabeth E Drye
Journal:  Ann Intern Med       Date:  2014-11-18       Impact factor: 25.391

Review 5.  Transhiatal versus transthoracic esophagectomy for esophageal cancer.

Authors:  J Camilo Barreto; Mitchell C Posner
Journal:  World J Gastroenterol       Date:  2010-08-14       Impact factor: 5.742

6.  A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeown.

Authors:  Andrew M Brown; Michael J Pucci; Adam C Berger; Talar Tatarian; Nathaniel R Evans; Ernest L Rosato; Francesco Palazzo
Journal:  Surg Endosc       Date:  2017-06-22       Impact factor: 4.584

7.  Hospital readmission by method of data collection.

Authors:  Elizabeth M Hechenbleikner; Martin A Makary; Daniel V Samarov; Jennifer L Bennett; Susan L Gearhart; Jonathan E Efron; Elizabeth C Wick
Journal:  J Am Coll Surg       Date:  2013-04-11       Impact factor: 6.113

8.  Trends in the management of esophageal carcinoma based on provider volume: treatment practices of 618 esophageal surgeons.

Authors:  C K Enestvedt; K A Perry; C Kim; P W McConnell; B S Diggs; A Vernon; R W O'Rourke; J D Luketich; J G Hunter; B A Jobe
Journal:  Dis Esophagus       Date:  2009-06-09       Impact factor: 3.429

9.  Propensity Score-Matched Analysis Comparing Minimally Invasive Ivor Lewis Versus Minimally Invasive Mckeown Esophagectomy.

Authors:  Frans van Workum; Annelijn E Slaman; Mark I van Berge Henegouwen; Suzanne S Gisbertz; Ewout A Kouwenhoven; Marc J van Det; Frits J H van den Wildenberg; Fatih Polat; Misha D P Luyer; Grard A P Nieuwenhuijzen; Camiel Rosman
Journal:  Ann Surg       Date:  2020-01       Impact factor: 12.969

Review 10.  Comparison of short-term outcomes between minimally invasive McKeown and Ivor Lewis esophagectomy for esophageal or junctional cancer: a systematic review and meta-analysis.

Authors:  Jianqing Deng; Qingqing Su; Zhipeng Ren; Jiaxin Wen; Zhiqiang Xue; Lianbin Zhang; Xiangyang Chu
Journal:  Onco Targets Ther       Date:  2018-09-20       Impact factor: 4.147

View more
  8 in total

1.  Thirty years of esophageal cancer surgery in Oulu University Hospital.

Authors:  Henna Saviaro; Jukka Rintala; Joonas H Kauppila; Fredrik Yannopoulos; Sanna Meriläinen; Vesa Koivukangas; Heikki Huhta; Olli Helminen; Juha Saarnio
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 3.005

2.  Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma.

Authors:  Jifeng Feng; Lifen Wang; Liang Wang; Xun Yang; Guangyuan Lou
Journal:  BMC Cancer       Date:  2022-03-17       Impact factor: 4.430

Review 3.  Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy.

Authors:  Keouna Pather; Erin M Mobley; Christina Guerrier; Rhemar Esma; Heather Kendall; Ziad T Awad
Journal:  World J Surg Oncol       Date:  2022-02-25       Impact factor: 2.754

Review 4.  Selection of minimally invasive surgical approaches for treating esophageal cancer.

Authors:  Yu-Kwang Lee; Ke-Cheng Chen; Pei-Ming Huang; Shuenn-Wen Kuo; Mong-Wei Lin; Jang-Ming Lee
Journal:  Thorac Cancer       Date:  2022-06-15       Impact factor: 3.223

5.  The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer.

Authors:  Hailei Du; Shuai Pang; Yong Li; Lianggang Zhu; Junbiao Hang; Ling Chen
Journal:  J Gastrointest Oncol       Date:  2022-08

6.  Pathologic Complete Response Prediction to Neoadjuvant Immunotherapy Combined with Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: Real-World Evidence from Integrative Inflammatory and Nutritional Scores.

Authors:  Jifeng Feng; Liang Wang; Xun Yang; Qixun Chen; Xiangdong Cheng
Journal:  J Inflamm Res       Date:  2022-07-06

7.  The role of surgery type in postoperative atrial fibrillation and in-hospital mortality in esophageal cancer patients with preserved left ventricular ejection fraction.

Authors:  Laite Chen; Lu Zhang; Lu Shi; Guosheng Fu; Chenyang Jiang
Journal:  World J Surg Oncol       Date:  2020-09-11       Impact factor: 2.754

8.  Comparative analysis of long-term oncologic outcomes for minimally invasive and open Ivor Lewis esophagectomy after neoadjuvant chemoradiation: a propensity score matched observational study.

Authors:  Robert E Merritt; Peter J Kneuertz; Mahmoud Abdel-Rasoul; Desmond M D'Souza; Kyle A Perry
Journal:  J Cardiothorac Surg       Date:  2021-12-06       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.